CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $706,534 | +43.7% | 26,069 | +18.1% | 0.00% | 0.0% |
| Q2 2023 | $491,562 | -97.7% | 22,076 | -97.7% | 0.00% | -96.2% |
| Q1 2023 | $21,269,814 | +2062.5% | 981,078 | +1917.2% | 0.03% | +2500.0% |
| Q4 2022 | $983,587 | +12.8% | 48,635 | +45.3% | 0.00% | 0.0% |
| Q3 2022 | $872,000 | +100.9% | 33,482 | +84.7% | 0.00% | 0.0% |
| Q2 2022 | $434,000 | -10.3% | 18,127 | -15.6% | 0.00% | 0.0% |
| Q1 2022 | $484,000 | -2.8% | 21,485 | -14.2% | 0.00% | – |
| Q4 2021 | $498,000 | +57.6% | 25,040 | +56.5% | 0.00% | – |
| Q3 2021 | $316,000 | -37.2% | 15,998 | -29.7% | 0.00% | -100.0% |
| Q2 2021 | $503,000 | +33.8% | 22,741 | +45.1% | 0.00% | – |
| Q1 2021 | $376,000 | +0.8% | 15,676 | +9.9% | 0.00% | – |
| Q4 2020 | $373,000 | +41.8% | 14,264 | -23.5% | 0.00% | – |
| Q3 2019 | $263,000 | +182.8% | 18,634 | +44.8% | 0.00% | – |
| Q4 2016 | $93,000 | – | 12,868 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
| Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
| Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
| S&T BANK/PA | 350,924 | $7,601 | 1.37% |
| Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
| Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
| Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |